14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
DCTH vs TNDM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Delcath Systems Inc (DCTH) is the stronger overall head-to-head candidate over Tandem Diabetes Care, Inc. (TNDM) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DCTH carries a Unified Composite Score of 35.9/100 (SELL) at $19.68 (N/M Forward P/E, 5.2% operating margin), whereas TNDM carries 37.1/100 (SELL) at $19.11 (N/M Forward P/E, -2.4% operating margin).
Composite vs. Pillar Nuance: While TNDM currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. DCTH 35.9/100 SELL), DCTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (5.2% vs. -2.4% operating margin) and revenue trajectory (+70.7% vs. +13.8% YoY).
Defensive Composite Rating Caution: Although DCTH compares more favorably head-to-head, both DCTH (35.9/100 SELL) and TNDM (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Competes within the Medical Devices value chain with $1.2B market capitalization and -2.4% operating margin.
OpEx & R&D Reinvestment59.0% of Rev ($635M)
90D Engineering Disclosures0 Published
Investor FAQ DCTH vs TNDM Key Questions & Quantitative Answers
As of Nov 16, 2026, Delcath Systems Inc (DCTH) is the stronger overall head-to-head candidate over Tandem Diabetes Care, Inc. (TNDM) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DCTH carries a Unified Composite Score of 35.9/100 (SELL) at $19.68 (N/M Forward P/E, 5.2% operating margin), whereas TNDM carries 37.1/100 (SELL) at $19.11 (N/M Forward P/E, -2.4% operating margin). Composite vs. Pillar Nuance: While TNDM currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. DCTH 35.9/100 SELL), DCTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (5.2% vs. -2.4% operating margin) and revenue trajectory (+70.7% vs. +13.8% YoY). Defensive Composite Rating Caution: Although DCTH compares more favorably head-to-head, both DCTH (35.9/100 SELL) and TNDM (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
DCTH leads the Growth & Scale pillar: DCTH posts +70.7% YoY revenue growth and +750.0% YoY earnings growth on $110M TTM revenue (87.6% gross margin, 5.2% operating margin), compared with TNDM at +13.8% YoY revenue growth and -37.0% YoY earnings growth on $1.08B TTM revenue (56.6% gross margin, -2.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), DCTH cumulative revenue shifted +125.0% while TNDM shifted +461.1%. In operating R&D and SG&A reinvestment, DCTH deploys 82.4% of Rev ($91M) (0 90-day corporate R&D disclosures) versus 59.0% of Rev ($635M) (0 disclosures) for TNDM.
TNDM screens cheaper on headline valuation multiples. DCTH trades at N/M Forward P/E, 133.6x Trailing P/E, 1.60x PEG, and 6.3x EV/Revenue (18.3% FCF margin), whereas TNDM trades at N/M Forward P/E, 55.2x Trailing P/E, N/M PEG, and 1.8x EV/Revenue (-6.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DCTH (5.4% ROE) versus TNDM (-36.7% ROE) capital efficiency.
In options market volatility and institutional positioning, DCTH carries 109.3% implied volatility (43rd %ile, Balanced (25th–60th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.63β · 131% Vol realized risk). By comparison, TNDM carries 77.8% implied volatility (10th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.15β · 88% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.